Total Voting Rights

Source: RNS
RNS Number : 2475K
Ceres Power Holdings plc
31 October 2024
 

31 October 2024

Ceres Power Holdings plc

("Ceres Power" or "the Company")

 

Total Voting Rights

 

Ceres Power confirms that as at 31 October 2024, the Company had 193,699,380 Ordinary Shares in issue, with one voting right each.

The Company does not hold any shares in treasury.  The number of Ordinary Shares with voting rights is therefore 193,699,380.

Accordingly, these figures may be used by shareholders as a denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

For further information visit www.ceres.tech or contact:

Ceres Power Holdings plc

Stuart Paynter (Chief Financial Officer)

 

Tel: +44 (0)7810 813607

Email: stuart.paynter@cerespower.com

FTI Consulting (PR Adviser)

Dwight Burden

Tel: +44 (0)203 727 1000

Email: ceres_power@fticonsulting.com

 

About Ceres

Ceres is a leading developer of clean energy technology: electrolysis for the production of green hydrogen and fuel cells for power generation. Its asset-light, licensing model has seen it establish partnerships with some of the world's largest companies, such as Bosch, Doosan, Delta, Denso, Shell, Thermax and Weichai. Ceres' solid oxide technology supports greater electrification of our energy systems and produces green hydrogen at high efficiencies as a route to decarbonise emissions-intensive industries such as steelmaking, ammonia and future fuels. Ceres is listed on the London Stock Exchange ("LSE") (LSE: CWR) and is classified by the LSE Green Economy Mark, which recognises listed companies that derive more than 50% of their activity from the green economy. Read more on our website www.ceres.tech or follow us on LinkedIn.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAEEEDLNLFFA